Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 15 02 2020
accepted: 22 09 2020
pubmed: 15 10 2020
medline: 15 12 2020
entrez: 14 10 2020
Statut: ppublish

Résumé

Osteogenesis imperfecta (OI) is characterized primarily by susceptibility to fractures with or without bone deformation. OI is genetically heterogeneous: over 20 genetic causes are recognized. We identified bi-allelic pathogenic KDELR2 variants as a cause of OI in four families. KDELR2 encodes KDEL endoplasmic reticulum protein retention receptor 2, which recycles ER-resident proteins with a KDEL-like peptide from the cis-Golgi to the ER through COPI retrograde transport. Analysis of patient primary fibroblasts showed intracellular decrease of HSP47 and FKBP65 along with reduced procollagen type I in culture media. Electron microscopy identified an abnormal quality of secreted collagen fibrils with increased amount of HSP47 bound to monomeric and multimeric collagen molecules. Mapping the identified KDELR2 variants onto the crystal structure of G. gallus KDELR2 indicated that these lead to an inactive receptor resulting in impaired KDELR2-mediated Golgi-ER transport. Therefore, in KDELR2-deficient individuals, OI most likely occurs because of the inability of HSP47 to bind KDELR2 and dissociate from collagen type I. Instead, HSP47 remains bound to collagen molecules extracellularly, disrupting fiber formation. This highlights the importance of intracellular recycling of ER-resident molecular chaperones for collagen type I and bone metabolism and a crucial role of HSP47 in the KDELR2-associated pathogenic mechanism leading to OI.

Identifiants

pubmed: 33053334
pii: S0002-9297(20)30329-3
doi: 10.1016/j.ajhg.2020.09.009
pmc: PMC7675035
pii:
doi:

Substances chimiques

Collagen Type I 0
HSP47 Heat-Shock Proteins 0
SERPINH1 protein, human 0
Vesicular Transport Proteins 0
KDELR2 protein, human 147097-18-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-999

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Références

Oncotarget. 2015 Feb 20;6(5):3375-93
pubmed: 25682866
Am J Hum Genet. 2009 Oct;85(4):521-7
pubmed: 19781681
Cell Cycle. 2007 Jul 15;6(14):1675-81
pubmed: 17630507
J Biol Chem. 2017 Oct 20;292(42):17216-17224
pubmed: 28860186
Int J Mol Sci. 2019 Nov 09;20(22):
pubmed: 31717602
FEBS J. 2019 Aug;286(15):3033-3056
pubmed: 31220415
Bone. 2006 Oct;39(4):901-6
pubmed: 16730480
J Biol Chem. 2016 Jun 10;291(24):12612-26
pubmed: 27129216
Transl Res. 2017 Mar;181:27-48
pubmed: 27914223
J Cell Biol. 2007 Dec 17;179(6):1193-204
pubmed: 18086916
Trends Biochem Sci. 2016 Feb;41(2):118-119
pubmed: 26749089
J Biol Chem. 2019 Feb 8;294(6):2133-2141
pubmed: 30541925
Cell. 1989 Mar 10;56(5):801-13
pubmed: 2647301
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
Am J Hum Genet. 2015 Mar 5;96(3):432-9
pubmed: 25683121
FEBS Lett. 2009 Dec 3;583(23):3863-71
pubmed: 19854180
Science. 2019 Mar 8;363(6431):1103-1107
pubmed: 30846601
Mol Genet Genomic Med. 2018 Jan;6(1):15-26
pubmed: 29150909
FASEB J. 2020 Jul 27;:
pubmed: 32716577
Am J Hum Genet. 2010 Mar 12;86(3):389-98
pubmed: 20188343
Hum Mol Genet. 2015 Apr 1;24(7):1918-28
pubmed: 25510505
Nat Cell Biol. 2008 Aug;10(8):912-22
pubmed: 18641641
Hum Mol Genet. 2013 Jan 1;22(1):1-17
pubmed: 22949511
Methods Enzymol. 1987;145:3-78
pubmed: 3600396
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481

Auteurs

Fleur S van Dijk (FS)

Expert Center for Adults with Osteogenesis Imperfecta, Isala Hospital, 10400 Zwolle, the Netherlands; Department of Clinical Genetics, University Medical Center Groningen, 30001 Groningen, the Netherlands; North West Thames Regional Genetics Service, London North West Health Care University NHS Trust, Harrow HA1 3UJ, UK; Department of Metabolism, Digestion and Reproduction, Section of Genetics and Genomics, Imperial College London, London, UK. Electronic address: fleur.dijk@nhs.net.

Oliver Semler (O)

Department of Paediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany; Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Julia Etich (J)

Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopaedic University Hospital Friedrichsheim gGmbH, Frankfurt/Main 60528, Germany.

Anna Köhler (A)

Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Juan A Jimenez-Estrada (JA)

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, Madrid 28029, Spain.

Nathalie Bravenboer (N)

Department of Clinical Chemistry, Amsterdam Movement Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Lauria Claeys (L)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Elise Riesebos (E)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Sejla Gegic (S)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Sander R Piersma (SR)

Department of Medical Oncology, Cancer center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Connie R Jimenez (CR)

Department of Medical Oncology, Cancer center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Quinten Waisfisz (Q)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Carmen-Lisset Flores (CL)

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, Madrid 28029, Spain.

Julian Nevado (J)

Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), ISCIII, Madrid 28029, Spain; Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz-IdiPaz-Universidad Autonóma de Madrid, Madrid 28046, Spain.

Arjan J Harsevoort (AJ)

Expert Center for Adults with Osteogenesis Imperfecta, Isala Hospital, 10400 Zwolle, the Netherlands.

Guus J M Janus (GJM)

Expert Center for Adults with Osteogenesis Imperfecta, Isala Hospital, 10400 Zwolle, the Netherlands.

Anton A M Franken (AAM)

Expert Center for Adults with Osteogenesis Imperfecta, Isala Hospital, 10400 Zwolle, the Netherlands.

Astrid M van der Sar (AM)

Department of Medical Microbiology and Infection Control, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Hanne Meijers-Heijboer (H)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Karen E Heath (KE)

Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), ISCIII, Madrid 28029, Spain; Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz-IdiPaz-Universidad Autonóma de Madrid, Madrid 28046, Spain; Skeletal Dysplasia Multidisciplinary Unit (UMDE), Hospital Universitario La Paz, Universidad Autonóma de Madrid, Madrid 28046, Spain.

Pablo Lapunzina (P)

Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), ISCIII, Madrid 28029, Spain; Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz-IdiPaz-Universidad Autonóma de Madrid, Madrid 28046, Spain.

Peter G J Nikkels (PGJ)

Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.

Gijs W E Santen (GWE)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.

Julian Nüchel (J)

Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Markus Plomann (M)

Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Raimund Wagener (R)

Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne 50931, Germany.

Mirko Rehberg (M)

Department of Paediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Heike Hoyer-Kuhn (H)

Department of Paediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Elisabeth M W Eekhoff (EMW)

Department of Internal Medicine Section Endocrinology, Amsterdam Movement Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Gerard Pals (G)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Matthias Mörgelin (M)

Colzyx AB, Medicon Village, Lund 22381, Sweden.

Simon Newstead (S)

Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.

Brian T Wilson (BT)

North West Thames Regional Genetics Service, London North West Health Care University NHS Trust, Harrow HA1 3UJ, UK; Biosciences Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne NE1 3BZ, UK.

Victor L Ruiz-Perez (VL)

Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, Madrid 28029, Spain; Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), ISCIII, Madrid 28029, Spain; Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz-IdiPaz-Universidad Autonóma de Madrid, Madrid 28046, Spain.

Alessandra Maugeri (A)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands.

Christian Netzer (C)

Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne 50931, Germany; Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.

Frank Zaucke (F)

Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopaedic University Hospital Friedrichsheim gGmbH, Frankfurt/Main 60528, Germany.

Dimitra Micha (D)

Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam 1081BT, the Netherlands. Electronic address: d.micha@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH